Chargement en cours...
An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin
PURPOSE: The aim of this study was to investigate the efficacy and tolerability of switching from 0.2 mg tamsulosin to 0.4 mg tamsulosin oral controlled absorption system (OCAS) over a 12-week period in Taiwanese men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplas...
Enregistré dans:
| Publié dans: | Clin Interv Aging |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5808696/ https://ncbi.nlm.nih.gov/pubmed/29445269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S152701 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|